Evercyte provide relevant human cell lines as model systems for cell based assays, production host, as well as for cellular therapy applications. Evercyte makes mainly use of the technology of reactivation of human telomerase by over expression of the catalytic subunit of this enzyme (hTERT). Evercyte has developed human highly differentiated cell lines from various human tissues that show stable growth characteristics and phenotypes and have a high potential for production of complex biopharmaceuticals such as recombinant proteins, vaccines or extracellular vesicles.